VEGFA and neoplasm: Apatinib is a small-molecule anti-angiogenic drug that efficiently inhibits the activity of VEGFR-2 tyrosine kinase, blocks signal transduction mediated by VEGF binding to the receptor, and inhibits tumor vascular endothelial cell migration and proliferation leading to strong anti-tumor impact.